Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05534087 |
| Consolidated Lead Sponsor | Seoul National University Hospital |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 236 participants (ESTIMATED) |
| Registered Start Date | 2022-12-15 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Dong-A University Hospital | Busan, South Korea | Open Hospital Dossier -> |
| Kyungpook National University Chilgok Hospital | Daegu, South Korea | Open Hospital Dossier -> |
| Chonnam National University Hwasun Hospital | Hwasun, South Korea | Open Hospital Dossier -> |
| Seoul National University Bundang Hospital | Seongnam, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.